Pharmaceutical Technology on MSN
Boehringer and Envisagenics to develop precision cancer therapies in $1bn deal
The partnership will focus on targets identified through Envisagenics’ SpliceCore AI platform.
Add Yahoo as a preferred source to see more of our stories on Google. Haylie Helms, M.S., an OHSU graduate student in biomedical engineering, is lead author on a review in Nature Reviews. Helms works ...
“Solid tumors are very diverse,” Zhu said. “Some tumor cells lose or hide the antigen a therapy is designed to find — what we ...
We also hoped to identify new targets that could lead to new drug developments," said Zhang, a McNair scholar and member of Baylor's Dan L Duncan Comprehensive Cancer Center. The team applied the data ...
Goto et al. 1 recently described a novel mechanism of immune evasion during the initial steps in the development of colorectal cancer in which nascent cancer cells reactivate a fetal program that is ...
The Scientific Forum’s technical sessions discussed the essential role of radiation medicine in cancer care and examined the building blocks for expanding and sustaining access to care.
New research looked at how cancers arise in children who are predisposed to developing the childhood kidney cancer, Wilms tumor, which could help anticipate the development of tumors before they fully ...
The gut microbiome plays a crucial role in cancer development and progression, by influencing the host immune system and metabolism. Dysbiosis, or a disruption in the balance of the host gut ...
New findings in a report led by the American Cancer Society (ACS) reveal an urgent picture of a growing global cancer burden and underscore the lifesaving potential of stronger prevention and ...
Researchers uncovered new potential therapeutic targets for cancer and new insights into existing cancer drug targets, expanding the breadth of possibilities for treating this disease. Researchers at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results